2020 CHEST Industry-Supported CME Satellite Symposia Schedule

Sunday, October 18

11:15 am – 12:15 pm

Redefining the Diagnosis and Therapy of COPD: Lessons From COPDGene, GOLD Reports, and Precision Medicine
Provided by Integrity Continuing Education, Inc. 
Supported by AstraZeneca 

Improving Outcomes in NTM-LD: Strategies for Diagnosis, Individualized Treatment Plans, and Patient Adherence
Provided by National Jewish Health
Supported by Insmed

When Is It PF-ILD? Diagnosis, Monitoring, and Treatment of a Complex Disease
Provided by Paradigm Medical Communications, LLC
Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. 

Improving Recognition and Management of EGPA: A Multidisciplinary Approach to Individualizing Treatment
Provided by PVI, PeerView Institute for Medical Education
Accredited by Medical Learning Institute, Inc.
Supported by an educational grant from GlaxoSmithKline

5:30 pm – 6:30 pm

Systemic Sclerosis Interstitial Lung Disease (SSc-ILD): The Importance of Early Diagnosis, Patient-centered Communication and Evidence-based Treatment
Provided by National Jewish Health
Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

“Holding Court” in Pulmonary Hypertension: You, the “Jury,” Decided the Verdict to Better Outcomes
Provided by Annenberg Center for Health Sciences at Eisenhower and Total CME
Supported by Actelion Pharmaceuticals US, Inc. 

Managing Influenza in At-risk Patients to Reduce Infection
Provided by Vindico Medical Education
Supported by an educational grant from Genentech, Inc.

Monday, October 19

5:45 pm – 6:45 pm

Emerging Treatments: Diagnosis and Treatment of Chronic Fibrosing ILD With a Progressive Lung Disease Phenotype
Provided by National Jewish Health
Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc

Management of Chronic Cough—Unmet Needs and Emerging Treatment Options
Provided by Vindico Medical Education and Merck & Co., Inc. 

Wednesday, October 21

4:45 pm – 5:45 pm

2020 CHEST Learning Theater Schedule

Monday, October 19

12:00 pm – 12:45 pm 

Behold…BREZTRI 
Sponsored by AstraZeneca

Enhanced Performance of the Nodify XL2^®Blood-Based Lung Nodule Test Through the Nodify Lung™ Integrated Testing Strategy
Sponsored by Biodesix, Inc.

The Current State of OFEV^® (Nintedanib) Capsules: A Treatment Journey 
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc

Management of Adults With Asthma or COPD With Inhaled Maintenance Treatment Options 
Sponsored by GlaxoSmithKline

Clinical Insights in VTE: Treatment and Risk Reduction Through Prophylaxis
Sponsored by Janssen Pharmaceuticals, Inc.

Tuesday, October 20

12:00 pm – 12:45 pm 

REPLACE (Riociguat rEplacing PDE-5i Therapy EvaLuated Against Continued PDE-5i thErapy): A Look at Phase IV Study Data
Sponsored by Bayer

The Clinical Utility of the BioFire Pneumonia Panel During the COVID-19 Pandemic
Sponsored by BioFire Diagnostics

“What Was Old Is New Again”: A Novel, More Bioavailable Antifungal
Sponsored by Mayne Pharma

Modernized Tetracycline for the Treatment of Adults With CABP and ABSSSI
Sponsored by Paratek Pharmaceuticals

The Role of Type-2 Inflammation in Asthma and CRSwNP
Sponsored by Sanofi Genzyme and Regeneron

Wednesday, October 21

12:30 pm – 1:15 pm

Exploring Idiopathic Pulmonary Fibrosis (IPF) With the Experts 
Sponsored by Genentech

New Advancements in Respiratory Health: From Hospital to Home 
Sponsored by Hillrom

Rethinking the Role of Nebulization in the Maintenance Treatment of COPD
Sponsored by Mylan, Inc.

Prerecorded Learning Theaters

Targeting a Common Contributor to Severe Asthma 
Sponsored by AstraZeneca

Thinking Differently About Asthma Management: Revisiting the Window of Opportunity
Sponsored by AstraZeneca

TSLP: A Key Epithelial Cytokine at the Top of the Asthma Inflammatory Cascade
Sponsored by AstraZeneca and Amgen

Recognizing Chronic Fibrosing Interstitial Lung Disease With a Progressive Phenotype: A Focus on Radiology
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.

Advances in the Diagnosis & Treatment of PE
Sponsored by Boston Scientific

Treatable Traits Approach Towards COPD Management for Busy Pulmonologists
Sponsored by GlaxoSmithKline

Recognizing Uncontrolled Asthma Is Only the First Step
Sponsored by GlaxoSmithKline

Chronic Rhinosinusitis, Nasal Polyps, and Asthma: The Unified Airway 
Sponsored by GlaxoSmithKline

Severe Eosinophilic Asthma: Recognition and Management of Co-morbidities
Sponsored by GlaxoSmithKline

Clinical and Real-world Evidence for Using a Biologic to Treat Severe Eosinophilic Asthma
Sponsored by GlaxoSmithKline

Clinical Overview of SUNOSI ^® and a Patient Case Study
Sponsored by Jazz Pharmaceuticals

Identifying and Managing Patients: The Value of Patient Management, Lung Health Programs, and LungGPS™ Patient Management Platform
Sponsored by Medtronic

Understanding Nasal Polyposis
Sponsored By Novartis Pharmaceutical Corporation

BLVR in the Trenches: High-volume Community Hospital Perspective
Sponsored by Olympus

Type-2 Inflammation in Asthma and COPD
Sponsored by Sanofi Genzyme and Regeneron

The Role of Type-2 Inflammation in Asthma and CRSwNP 
Sponsored by Sanofi Genzyme and Regeneron

Improving Lung Cancer and ILD Diagnostic Confidence With Percepta and Envisia Classifiers 
Sponsored by Veracyte